Publicaciones (68) Publicaciones de MARÍA ÁNGELES ORELLANA MIGUEL

2024

  1. Bacteremia due to Leuconostoc species: A 13-year single-center case series

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 3, pp. 149-151

  2. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

2023

  1. Antibiotic resistance in bloodstream isolates from high-complexity paediatric units in Madrid, Spain: 2013–2021

    Journal of Hospital Infection, Vol. 139, pp. 33-43

  2. Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption

    Cancers, Vol. 15, Núm. 23

  3. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  4. Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial

    BMJ open, Vol. 13, Núm. 9, pp. e072121

  5. Increased risk of group B streptococcal sepsis and meningitis in HIV-exposed uninfected infants in a high-income country

    European Journal of Pediatrics, Vol. 182, Núm. 2, pp. 575-579

  6. Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 193-195

2022

  1. Clinical impact of time-to-positivity of blood cultures on mortality in patients with Pseudomonas aeruginosa bacteremia

    Journal of Global Antimicrobial Resistance, Vol. 30, pp. 269-275

  2. Determining Time to Positivity of Blood Cultures in a Neonatal Unit

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 11, pp. 510-513

  3. Genomic Analysis of Ceftazidime/Avibactam-Resistant GES-Producing Sequence Type 235 Pseudomonas aeruginosa Isolates

    Antibiotics, Vol. 11, Núm. 7

  4. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018

    Emerging Infectious Diseases, Vol. 28, Núm. 5, pp. 967-976

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia

    International Journal of Antimicrobial Agents, Vol. 58, Núm. 6

  3. Eradication of staphylococcus aureus post-sternotomy mediastinitis following the implementation of universal preoperative nasal decontamination with mupirocin: An interrupted time-series analysis

    Clinical Infectious Diseases, Vol. 73, Núm. 9, pp. 1685-1692

  4. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

2020

  1. Direct identification of pneumococcal serotypes in blood cultures by a PCR-reverse-hybridisation technique

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 170-173

  2. First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 410-416

  3. Impact of duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 10, pp. 3049-3055

  4. Improved blood culture workflow in the time to detection of microorganisms placing incubators systems outside of microbiology laboratory

    Brazilian Journal of Microbiology, Vol. 51, Núm. 3, pp. 1103-1108